Tablets for treating flea infestations, ideal for feeding with or without food. With nitenpyram as the active ingredients, suitable for large dogs weighing over 11.1kg.
CAPSTAR 57mg for Large Dogs are tablets for large dogs, containing nitenpyram as an active ingredient. This neonicotinoid inhibits the transmission of excitation, which helps to fight pest infestations by causing the death of adult fleas.
CAPSTAR 57mg for Large Dogs at a glance:
- Tablets to fight flea infestations in large adult dogs over 11.1kg
- Tablets with 57mg nitenpyram: for the treatment of flea infestations
- Kills fleas (Ctenocephalides felis): effects on fleas can be seen as rapidly as 15 - 30 minutes after administering the tablets to your pet. This occurs at the same time as the fleas' first blood meal after sufficient blood levels are reached in the host animal. They can be 95-100% effective within the first 6 hours. 100% efficacy can be achieved within 24 hours, without residual activity.
- Further information:
- Use during pregnancy or lactation: nitenpyram can be administered during pregnancy or lactation. Laboratory studies (on rats and rabbits) showed no signs of teratogenic- or foetotoxic effects. The tolerability of the product has been shown in pregnant and lactating cats and -dogs.
Contraindications:
According to the manufacturer, there are no known contraindications.
Side effects:
Pets may experience increased itching in the first hour after administering the CAPSTAR 57mg for Large Dogs. This effect is caused by the fleas reacting to the product. In very rare cases, your dog may experience temporary hyperactivity, panting, vocalisation and excessive grooming/licking. Very rarely, transient neurological symptoms such as muscle tremors, ataxia and convulsions have been reported.
The frequency of side effects is defined as follows:
- Very common (more than 1 in 10 treated animals show side effects)
- Common (more than 1 but less than 10 out of 100 treated animals)
- Occasional (more than 1 but less than 10 out of 1000 treated animals)
- Rare (more than 1 but less than 10 in 10,000 treated animals)
- Very rare (less than 1 in 10,000 treated animals, including individual case reports)
The Federal Office of Consumer Protection and Food Safety, Mauerstraße 39-42, 10117 Berlin or the pharmaceutical company should be notified of any adverse reactions.
Interactions with other medicinal products and other interactions:
None known. In clinical studies, no adverse drug reactions were observed with nitenpyram was used alongside other veterinary products, including other common flea products, anthelmintics, vaccines or antibiotics.
For risks and side effects, please read the enclosed leaflet and consult your veterinarian or pharmacist.
For further information on pharmaceutical products sold through our pharmacy, please contact us at:
e-pharmacy@zooplus.com.
Marketing authorisation holder in Germany: Elanco GmbH, Heinz-Lohmann-Str. 4, D-27472 Cuxhaven